Differentiating Manganism from Idiopathic Parkinsonism: Yangho KIM, et al. Industrial Health Research Institute, Korea Industrial Safety Corporation (KISCO)-It is difficult to distinguish manganism and idiopathic parkinsonism from each other, especially in the settings where an isolated patient with parkinsonism has spent time in a manganese (Mn)-exposed working environment. We performed clinical examinations and laboratory studies including mangetic resonance imaging (MRI) and positron emission tomography (PET) in two Mnexposed workers (cases 1 and 2) who had parkinsonian features. The clinical features of case 1, however, were rather different from those of case 2, although both of them have some common parkinsonian features such as bradykinesia, tremor and rigidity. MRI in case 1 showed no abonormaities, but in case 2 showed symmetrical high signal intensities in the globus pallidus on a T1 weighted image. On PET findings, Ki values in the striatum were within the normal range in case 1, but reduced 18 F-6-fluorodopa uptake in the left putamen was seen in case 2. PET provides information of considerable value in discriminating between idiopathic parkinsonism and mangnism. (J Occup Health 1999; 41: 91-94) 
extrapyramidal symptom complex such as parkinsonism develops in workers exposed to Mn. The clinical features of manganism are, however, similar to those of idiopathic parkinsonism. As workers work until older ages than in the past, they are more liable to get neurodegenerative diseases such as idiopathic parkinsonism during their active working lifetime. It is therefore difficult to distinguish manganism and idiopathic parkinsonism from each other, especially in settings in which an isolated patient with parkinsonism has spent time in a Mn-exposed working environment, although the differential diagnosis is somewhat easier in the context of outbreaks.
We report the similarities and differences between a case of idiopathic parkinsonism with superimposed manganese exposure and a case of manganism, and discuss the value of 18 F-6-fluorodopa ( 18 F-dopa) positron emission tomography (PET) in differential diagnosis.
Patients and methods
A patient with remote exposure to Mn (case 1), a 51-year-old male, is one of six well-documented cases of manganism who had worked in the same factory employing about 20 workers over 10 years ago 1) . They had prepared manganese powder for welding rods by crushing ferromanganese and treated the rods with acid or alkali. Six workers had complained of symptoms similar to parkinsonian features. The patient had worked for one year in the factory and had quit the job because of tremors and gait disturbances in 1985. Since then he has had no exposure. Out of six workers, one died, and two are in a bed-ridden state because of secondary complications such as hip fracture or head trauma without showing such typical neurologic symptoms as at the first diagnosis of manganism. One could not be followed up, and the remaining two workers still showed such typical neurologic symptoms as they complained of at the diagnosis of manganism. Case 1 is one of the remainder.
A patient with recent exposure to Mn (case 2), a 48-year-old male, had been a welder for over 10 years. He had welded at several workplaces for two hours daily for 10 years, and in the latest workplace for 10 hours a day for the last two years. He had quit the job due to neurologic deficits such as tremors and rigidity in 1996, and had no exposure thereafter.
Blood and urinary Mn was measured by flameless atomic absorption spectrometry (Varian SpectraAA, Varian Techtron Pty, Victoria, Australia).
We performed magnetic resonance imaging (MRI) scan on case 1, 12 years after the cessation of exposure to Mn, and on case 2 at the time of both 10 days and six months after the cessation of exposure.
PET scans were performed as follows; The patients were given 100 mg of oral carbidopa one hour before scanning. The PET scan was performed with an ECAT EXACT HR (Siemens/CTI, Knoxville, Tenn., USA). Images were reconstructed by filtered backprojection, resulting in 47 slices with a 128 × 128 matrix (pixel size 1.8 mm) and interplane separation of 3.125 mm. Correction for tissue attenuation of 511 keV gamma radiation was measured with an external Ge-68 ring. . We used the time frames from 25 to 94 min post-injection with occipital counts as the input function. ROI (region of interest) analysis was performed on the Ki images. The ROIs were placed on three contiguous planes containing caudate and putamen by image inspection with reference to the stereotactic atlas of Talairach and Tournoux 4) . One circular ROI of 63.6 mm 2 (diameter = 9 mm) was positioned by inspection on each caudate nucleus. One elliptical 152.6 mm 2 ROI was placed on each putamen.
Results

Patients
One patient with remote exposure to Mn (case 1) and the other with recent exposure (case 2) have showed some common parkinson-like features such as bradykinesia, tremors and rigidity in the present neurologic examination (Table 1) . Case 1 showed severe postural instability, the so called "cock walk", turning difficulty and a particular propensity to fall in backward gait. Severe action tremor in both hands and dystonia in his left hand was remarkable. At first he showed a mild response to levodopa, which was not sustained. Compared with previous symptom and signs, those seen at present had not been aggravated for 12 years. Clinical features of case 2, however, were rather different from those of case 
Laboratory findings
The blood and urine Mn concentrations analyzed after two months of cessation of exposure were 3.26 µg/dl and 3.57 µg/l (normal <2 µg/dl and 2 µg/l, respectively) 5) in case 2. The urinary Mn concentration (73.3 µg/day) obtained after treatment with 1 g EDTA IV had increased significantly compared to the prechelation level of 13.6 µg/day. There was, however, no significant increase in urinary cadmium or lead concentrations. And the mean level of exposure to Mn fumes for other welders in the factory where case 2 worked was 0.63 mg/m 3 , but we had no biological monitoring data for case 1. MRI showed no abonormalities in case 1 (Fig. 1) , but there were symmetrical high signal intensities in the globus pallidus on a T1 weighted image in case 2 (Fig. 2) . T2 signals were unremarkable. Repeated MRI six months after the first one showed almost complete resolution of the high signal intensities in the globus pallidus (Fig. 2) .
Ki values in the striatum on PET scan are shown in Table 1 .
Ki values in the striatum were within the normal range in case 1, but were reduced in the left putamen in case 2. PET scan showed normal 18 F-dopa uptake in the striatum in case 1 (Fig. 3) and reduced 18 F-dopa uptake in the left putamen in case 2 (Fig. 4) .
Discussion
Mn exposure histories in the workplace, the temporal relationship between the exposure and onset of symptoms and signs, and simultaneous development of similar diseases in fellow workers in the same factory strongly suggest that the parkinsonian features in case 1 were induced by Mn. Case 1 showed typical neurologic features such as severe postural instability, a particular propensity to fall in backward gait, the so-called cock walk, predominant action tremor, and dystonia at first, which are frequently observed in manganism. The clinical signs were sustained after the cessation of exposure to Mn. Occupational history, a mild increase in the blood and urine Mn concentrations, and a significant increase in the urinary Mn concentration after EDTA treatment indicate overexposure to Mn in case 2. The clinical signs in case 2 were compatible with parkinsonism, but predominant unilateral resting tremor and lack of gait disturbance or dystonia can be compared to the clinical features in case 1, frequently observed in manganism 6) . These clinical features in case 2 suggest idiopathic parkinsonism, although it is somewhat difficult to make a final diagnosis with clinical signs only.
Experimental Mn poisoning of the primate, a Mn overload of prolonged total parenteral nutrition or chronic liver disease produces symmetrical high signal intensities in the basal ganglia, midbrain and pons in T1 weighted MRI of the brain [7] [8] [9] . Resolution of this signal, usually within six months, reflects clearance of Mn from the brain despite permanent neurological damage 8, 10, 11) . The two MRI findings in case 2 showed exposure to Mn and clearance of Mn from the brain. A normal MRI result in case 1 is also reasonable considering the long term cessation of exposure. These findings suggest that high signal intensities on T1-weighted image reflect current exposure to Mn.
18
F-dopa PET provides an index of the integrity of the dopaminergic nigrostriatal pathway, the primary focus of neurodegeneration in idiopathic parkinsonism, and is abnormal in idiopathic parkinsonism 3, 12, 13) . There is reduced uptake in the striatum, particularly the posterior putamen 6) . This finding is in accord with the knowledge that there is a 40 to 60% loss of dopaminergic cells in the nigrostriatal pathway. In nonhuman primates that had been intoxicated with Mn, the 18 F-dopa PET scan was normal 14, 15) , compatible with the pallidum being the epicenter of damage induced by manganese. PET findings in human manganism are, however, limited to a group of four cases in a Taiwanese ferromanganese smelting plant 16) . The PET findings in case 1 showed normal 18 F-dopa uptake in the striatum, as shown in the Taiwanese manganism cases. This result indicated that in manganism there are normal PET findings. PET scan in case 2, however, showed reduced 18 F-dopa uptake in left putamen. This finding with such clinical features as predominent unilateral resting tremor, and lack of gait disturbance or dystonia shows that case 2 is one of idiopathic parkinsonism with superimposed manganese exposure. We therefore should be prudent in diagnosing an isolated parkinsonism case as manganism even though the patient has definitely been exposed to Mn. These results indicate that PET provides information of considerable value in differentiating manganism from idiopathic parkinsonism.
